Obesity and myelomeningocele: Anthropometric measures

Journal of Spinal Cord Medicine

Volumn 33, Issue 4, 2010, Pages 410-419

  Shurtleff, David B ^a,b   Walker, William Otis ^a,b   Duguay, Sharon ^b   Peterson, Do ^b   Cardenas, Diana ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Anthropometric measures; Body mass index; Myelomeningocele; Obesity; Paralysis; Spina bifida

Indexed keywords

ADOLESCENT; ADULT; ANTHROPOMETRY; ARM; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; OBESITY; PARALYSIS; PRESCHOOL CHILD; SCHOOL CHILD; SCOLIOSIS;

EID: 78449298966     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2010.11689720     Document Type: Article

References (41)

1. Hayes-Allen MC. Obesity and short stature in children with meningomyelocele. Dev Med Child Neurol. 1972;14(suppl 22):59-64.
2. Charney EB, Rosenblum M, Finegold D. Linear growth in a population of children with meningomyelocele. Zinderchir. 1981;34(4):415-419.
3. Shurtleff DB. Dietary management. In: Shurtleff DB, ed. Myelodysplasias and Exstrophies, Significance, Prevention and Treatment. Orlando, FL: Grune & Stratton; 1986:285-298.
4. Roberts D, Shepard RW, Shepard K. Anthropometry and obesity in meningomyelocele. J Pediatr Child Health. 1991; 27(2):83-90.
5. Littlewood RA, Trocki O, Shepard RW, Shepard K, Davies PSW. Resting energy expenditure and body composition in children with meningomyelocele. Pediatr Rehabil. 2003; 6(1):31-37.
6. Ausili E, Focrelli B, Tabacco F, et al. Bone mineral density and body composition in a myelomeningocele children population: effects of walking ability and sport activity. Eur Rev Med Pharmacol Sci. 2008;12(6):349-354.
7. Grogan CB, Ekval SM. Body composition of children with meningomyelocele determined by 40,000 urinary creatinine and anthropometric measures. J Am Coll Nutr. 1999; 18(4):316-323.
8. Larsson I, Henning B, Lindroos AK, et al. Optimized predictions of absolute and relative amounts of body fat from weight, height other anthropometric predictors, and age. Am J Clin Nutr. 2006;83(2):252-259.
9. Liusuwan RA, Widman LM, Abresch RT, et al. Body composition and resting energy expenditure in patients aged 11 to 21 years with spinal cord dysfunction compared to controls: comparison and relationships among the groups. J Spinal Cord Med. 2007;30(suppl 1):S105-S111.
10. Duval-Beaupere G, Kaci M, Lougovoy J, Caponi MF, Touzeau C. Growth of trunk and legs of children with meningomyelocele. Dev Med Child Neurol. 1987;29(2): 225-231.
11. Shepherd K, Roberts D, Golding S, Thomas BJ, Shepherd RW. Body composition in meningomyelocele. Am J Clin Nutr. 1991;53(1):1-6.
12. Shurtleff DB, Gordon LH, Goiney R, et al. Myelodysplasia: the natural history of kyphosis and scoliosis: a preliminary report. Dev Med Child Neurol. 1976;18(suppl 37):126-133.
13. Brown JK, Feng JY, Knapp TB. Self reported height or arm span more accurate alternative measure of height? Clin Nurs Res. 2002;11(4):417-432.
14. Hepper NGG, Black LF, Fowler WS. Relationships of lung volumes to height and arm span in normal subjects and in patients with spinal deformity. Am Rev Respir Dis. 1965; 91(Mar):356-362.
15. Hochhaus F. One year treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: a comparison of supine length and arm span J Pediatr Endocrinol Metab. 1999;12(2):153-159.
16. Jarzem PF, Gledhill RB. Predicting height from arm span measurements. J Pediatr Orthop. 1993;13(6):761-765.
17. Miller F, Koreska J. Height measurement of patients with neuromuscular disease and contractures. Dev Med Child Neurol. 1992;34(1):55-60.
18. Satin-Smith M, Katz L, Thornton F, et al. Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and growth deficiency. Clin Endocrinol Metab. 1996; 81(90):1654-1656.
19. Sherman MS, Kaplan JM, Effgen S, et al. Pulmonary dysfunction and reduced exercise capacity in patients with meningomyelocele. J Pediatr. 1997;131(3):413-418.
20. Rotenstein D. Arm span as a measure of response to GH treatment. J Clin Endocrinol Metab. 1996;81(9):3432.
21. Rotenstein D, Adams M, Reigel DH. Adult stature and anthropometric measurements of patients with myelomeningocele. J Pediatr. 1995;154(5):398-402.
22. Stevenson RD. Use of segmental measures to estimate stature in children with cerebral palsy. Arch Pediatr Adolesc Med. 1995;149(6):658-662.
23. Centers for Disease Control and Prevention. National Center for Health Statistics [updated 2009 August 4; cited 2007 September 9]. Available at: http://www.cdc.gov/nchs/growthcharts/clinical-charts.htm. Accessed August 30, 2010.
24. Shurtleff DB. Computer databases for pediatric disability: clinical and research applications. Phys Med Rehabil Clin N Am. 1991;2(4):665-687.
25. Shurtleff DB, Lamers J, Goiney T, et al. Are myelodysplastic children fat? Anthropometric measures: a preliminary study. Spina Bifida Ther. 1982;4(1):1-21.
26. McDonald CM, Jaffe KM, Mosca VS, Shurtleff DB. Ambulatory outcome of children with myelomeningocele: effect of lower extremity muscle strength. Dev Med Child Neurol. 1991;33(6):482-490.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310.
28. Engelbach W. Endocrine Medicine. Vol I. Springfield, IL: Charles C Thomas; 1932:261-312.
29. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
30. Hardin JW, Hilbe JM. Generalized Estimating Equations. Boca Raton, FL: Chapman & Hall/CRC; 2003.
31. Belt-Niedbala BJ, Ekvall S, Cook CM, et al. Linear growth measurement: a comparison of single arm lengths and arm span. Dev Med Child Neurol. 1986;28(3):319-324.
32. Trollmann R, Strehl E, Dorr HG. Precocious puberty in children with myelomeningocele: treatment with gonadotropin-releasing hormone and analogues. Dev Med Child Neurol. 1998;40(1):38-43.
33. Manenica K. Identification of Factors Related to Obesity in Children With Myelomeningocele [thesis]. Seattle, WA: University of Washington; 1982.
34. Rickard K, Brady MS, Gresham EL. Nutritional management of the chronically ill child: congenital heart disease and myelomeningocele. Pediatr Clin N Am. 1977;24(1):157-175.
35. Fiore P, Picco P, Castagnola E, et al. Nutritional survey of children and adolescents with myelomeningocele (MMC): overweight associated with reduced energy intake. Eur J Pediatr Surg. 1998;8(suppl 1):34-36.
36. Dosa NP, Foley JT, Eckrich M, Woodall-Ruff D, Liptak GS. Obesity across the lifespan among persons with spina bifida. Disabil Rehabil. 2008;30(11):1-7.
37. Asher J, Olsen M. Factors affecting the ambulatory status of patients with spina bifida cystica. J Bone J Surg. 1983;65(3): 350-356.
38. DeSouza LJ, Carroll M. Ambulation in the braced meningomyelocele patient. J Bone J Surg. 1976;58(8):1112-1118.
39. Liptak G, Shurtleff DB, Bloss JW, et al. Mobility aids for children with high-level meningomyelocele: parapodium versus wheelchair. Dev Med Child Neurol. 1992;34(9):787-796.
40. Menelaus MB. Orthopedic Management of Spina Bifida Cystica. 2nd ed. New York, NY: Churchill Livingstone; 1980:57-60.
41. Dietz WH. Childhood obesity: susceptibility, cause, and management. J Pediatr. 1983;103(11):676-686.